R1, a novel repressor of the human monoamine oxidase A

Kevin Chen1, Xiao-Ming Ou, Gao Chen

  • 1Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of California, Los Angeles, California 90033, USA.

Insights

A novel repressor protein, R1 (RAM2), has been identified that inhibits monoamine oxidase A (MAO-A) gene expression. This discovery sheds light on the regulation of MAO-A, a key enzyme in neurotransmitter metabolism.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Monoamine oxidase (MAO) enzymes are crucial for neurotransmitter metabolism.
  • A deficiency in monoamine oxidase A (MAO-A) is linked to aggressive behavior.
  • Sp1 transcription factors are known regulators of MAO-A gene expression.

Purpose of the Study:

  • To identify novel transcription factors regulating MAO-A gene expression.
  • To characterize a newly discovered repressor protein, R1 (RAM2).

Main Methods:

  • Yeast one-hybrid screening of a human cDNA library using MAO-A promoter sequences.
  • Transfection assays in human neuroblastoma cells (SK-N-BE (2)-C).
  • Gel-shift assays and chromatin immunoprecipitation (ChIP) assays.

Main Results:

  • A novel repressor, R1 (RAM2), was cloned and characterized.
  • R1 inhibited MAO-A promoter activity and enzymatic function in a dose-dependent manner.
  • R1 directly binds to the MAO-A promoter in vitro and in vivo, functioning as a transcriptional repressor.

Conclusions:

  • R1 (RAM2) is a novel repressor of monoamine oxidase A gene expression.
  • R1's nuclear and cytosolic localization suggests a role in transcriptional regulation.
  • R1 mRNA is expressed in human brain and peripheral tissues, indicating its physiological relevance.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...